CHRNA2 and prostate adenocarcinoma: In the TCGA‐PRAD dataset, low‐CHRNA2 (p = .03), low‐PAH (p = .029) and high‐JAG1 (p = .049) levels in PCa tissue samples were consistently associated with shorter PFS (Figure S3L–V; Table 2).